Presentation is loading. Please wait.

Presentation is loading. Please wait.

FIGURE 1 Percentage of patients with sarcopenia or low SMD across the spectrum of total adiposity (N = 3262). SMD, ... FIGURE 1 Percentage of patients.

Published byΘεοφάνια Μαρκόπουλος Modified over 5 years ago

Similar presentations

Presentation on theme: "FIGURE 1 Percentage of patients with sarcopenia or low SMD across the spectrum of total adiposity (N = 3262). SMD, ... FIGURE 1 Percentage of patients."— Presentation transcript:

1 FIGURE 1 Percentage of patients with sarcopenia or low SMD across the spectrum of total adiposity (N = 3262). SMD, ... FIGURE 1 Percentage of patients with sarcopenia or low SMD across the spectrum of total adiposity (N = 3262). SMD, skeletal muscle radiodensity. Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 American Society for Nutrition.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Am J Clin Nutr, Volume 109, Issue 3, 08 March 2019, Pages 615–625, The content of this slide may be subject to copyright: please see the slide notes for details.

2 FIGURE 2 Mean SMI and SMD by BMI and sex at diagnosis among patients with nonmetastatic CRC (males = 1634; ... FIGURE 2 Mean SMI and SMD by BMI and sex at diagnosis among patients with nonmetastatic CRC (males = 1634; females = 1628). CRC, colorectal cancer; HU, Hounsfield unit; SMI, skeletal muscle index; SMD, skeletal muscle radiodensity. Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 American Society for Nutrition.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Am J Clin Nutr, Volume 109, Issue 3, 08 March 2019, Pages 615–625, The content of this slide may be subject to copyright: please see the slide notes for details.

3 FIGURE 3 Mean SMI by race/ethnicity and sex for patients with nonmetastatic CRC: (A) male; (B) female. The estimated ... FIGURE 3 Mean SMI by race/ethnicity and sex for patients with nonmetastatic CRC: (A) male; (B) female. The estimated marginal means and conference intervals are from generalized linear models adjusted for age and BMI (*P value of mean difference <0.05 using Caucasians as the reference group). The interaction term between sex and race/ethnicity was tested using the likelihood ratio test and multivariate linear regression model (P < 0.001). CRC, colorectal cancer; SMI, skeletal muscle index. Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 American Society for Nutrition.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Am J Clin Nutr, Volume 109, Issue 3, 08 March 2019, Pages 615–625, The content of this slide may be subject to copyright: please see the slide notes for details.

4 FIGURE 4 Mean SMD by race/ethnicity and sex for patients with nonmetastatic CRC: (A) male; (B) female. The estimated ... FIGURE 4 Mean SMD by race/ethnicity and sex for patients with nonmetastatic CRC: (A) male; (B) female. The estimated marginal means and conference intervals are from generalized linear models adjusted for age and BMI (*P value of mean difference <0.05 based on Caucasians as the reference group). The interaction term between sex and race/ethnicity was tested with the likelihood ratio test and multivariate linear regression model (P < 0.001). CRC, colorectal cancer; HU, Hounsfield unit; SMD, skeletal muscle radiodensity. Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 American Society for Nutrition.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Am J Clin Nutr, Volume 109, Issue 3, 08 March 2019, Pages 615–625, The content of this slide may be subject to copyright: please see the slide notes for details.

Download ppt "FIGURE 1 Percentage of patients with sarcopenia or low SMD across the spectrum of total adiposity (N = 3262). SMD, ... FIGURE 1 Percentage of patients."

Similar presentations

FIGURE 1 Study subjects. KNHANES, Korean NHANES; 25(OH)D3, 25-hydroxyvitamin D3. From: Severe vitamin D deficiency is a risk factor for renal hyperfiltration.

FIGURE 1 Study subjects. KNHANES, Korean NHANES; 25(OH)D3, 25-hydroxyvitamin D3. From: Severe vitamin D deficiency is a risk factor for renal hyperfiltration.
Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 European Society of Cardiology and British Pharmacological.

Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 European Society of Cardiology and British Pharmacological.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
FIGURE 1 Association of habitual coffee intake with incident of CVD in the UK Biobank and in an earlier meta-analysis ... FIGURE 1 Association of habitual.

FIGURE 1 Association of habitual coffee intake with incident of CVD in the UK Biobank and in an earlier meta-analysis ... FIGURE 1 Association of habitual.
Figure 1 Data-selection process

Figure 1 Data-selection process
Figure 1 Flow diagram detailing the systematic review process.

Figure 1 Flow diagram detailing the systematic review process.
Figure 1 Schematic representation of the experimental design.

Figure 1 Schematic representation of the experimental design.
Figure 1 Mechanism of mortality benefit associated with radial access

Figure 1 Mechanism of mortality benefit associated with radial access
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Figure 1. Mean earnings of men and women over the early career (with 95 per cent confidence intervals) Figure 1. Mean earnings of men and women over the.

Figure 1. Mean earnings of men and women over the early career (with 95 per cent confidence intervals) Figure 1. Mean earnings of men and women over the.
FIGURE 1 Patient enrolment flowchart. SBS, short bowel syndrome.

FIGURE 1 Patient enrolment flowchart. SBS, short bowel syndrome.
Figure 1 Phases of the research. Author’s own work.

Figure 1 Phases of the research. Author’s own work.
FIGURE 1 Flowchart of the study population.

FIGURE 1 Flowchart of the study population.
Figure 1. Multivariable-adjusted hazard ratios (solid line) for incident chronic obstructive pulmonary disease as a ... Figure 1. Multivariable-adjusted.

Figure 1. Multivariable-adjusted hazard ratios (solid line) for incident chronic obstructive pulmonary disease as a ... Figure 1. Multivariable-adjusted.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1 Mean (±SE) egg investment in female zebra finches shortly after a second injection with either tetanus toxoid ... Figure 1 Mean (±SE) egg investment.

Figure 1 Mean (±SE) egg investment in female zebra finches shortly after a second injection with either tetanus toxoid ... Figure 1 Mean (±SE) egg investment.
AHA: American Heart Association; ALT: ...

AHA: American Heart Association; ALT: ...
Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.

Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.
Source: Figure created by the author based on data ...

Source: Figure created by the author based on data ...
bDMARD: biologic DMARD.

bDMARD: biologic DMARD.

Similar presentations

Ads by Google